Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -100.00K | -161.00K | -954.00K | -208.00 | ― |
EBITDA | 0.00 | -3.00 | -3.20M | -1.36M | -136.00K |
Net Income | -836.00K | -1.92M | -3.37M | -1.60M | 861.14K |
Balance Sheet | |||||
Total Assets | 1.87M | 1.45M | 1.14M | 234.97K | 33.67K |
Cash, Cash Equivalents and Short-Term Investments | 760.36K | 73.20K | 10.15K | 64.28K | 19.41K |
Total Debt | 1.44M | 1.44M | 1.03M | 160.00K | 825.79K |
Total Liabilities | 4.80M | 3.66M | 3.09M | 1.65M | 2.83M |
Stockholders Equity | -2.93M | -2.22M | -1.95M | -1.42M | -2.80M |
Cash Flow | |||||
Free Cash Flow | -67.84K | -1.79M | -4.18M | -1.19M | -147.12K |
Operating Cash Flow | -67.84K | -1.79M | -3.20M | -1.19M | -147.12K |
Investing Cash Flow | 0.00 | 0.00 | -980.56K | 0.00 | 0.00 |
Financing Cash Flow | 0.00 | 1.85M | 3.15M | 1.24M | 161.52K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
62 Neutral | C$6.49B | 9.24 | 3.44% | 2.90% | 6.99% | -11.09% | |
46 Neutral | C$238.61M | ― | -3.46% | ― | 29.27% | 42.35% | |
45 Neutral | C$10.52M | ― | -25.44% | ― | ― | 52.14% | |
40 Underperform | C$33.67M | ― | -14.09% | ― | ― | 13.91% | |
32 Underperform | C$1.64M | ― | -162.75% | ― | ― | 53.47% | |
32 Underperform | $2.00M | ― | -53.12% | ― | ― | -2147.62% | |
22 Underperform | C$7.72M | ― | 55.19% | ― | ― | 35.14% |
BacTech Environmental Corporation has secured CBOE approval for a royalty sale to Silver Crown Royalties Inc., providing a significant boost to BacTech’s financial outlook. The deal strengthens BacTech’s balance sheet with potential CAD$4 million in shares and offers upfront capital for its bioleaching facility in Ecuador, while maintaining focus on core operations. This 10-year agreement ensures long-term collaboration, aligning financial support with project milestones.